137 related articles for article (PubMed ID: 22693419)
1. Efficacy and safety of a switch to latanoprost 0.005% + timolol maleate 0.5% fixed combination eyedrops from latanoprost 0.005% monotherapy.
Inoue K; Fujimoto T; Higa R; Moriyama R; Kohmoto H; Nagumo H; Wakakura M; Tomita G
Clin Ophthalmol; 2012; 6():771-5. PubMed ID: 22693419
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of switching to latanoprost 0.005%-timolol maleate 0.5% fixed-combination eyedrops from an unfixed combination for 36 months.
Inoue K; Okayama R; Higa R; Tomita G
Clin Ophthalmol; 2014; 8():1275-9. PubMed ID: 25061275
[TBL] [Abstract][Full Text] [Related]
3. Assessment of ocular hypotensive effect and safety 12 months after changing from an unfixed combination to a latanoprost 0.005% + timolol maleate 0.5% fixed combination.
Inoue K; Okayama R; Higa R; Wakakura M; Tomita G
Clin Ophthalmol; 2012; 6():607-12. PubMed ID: 22553420
[TBL] [Abstract][Full Text] [Related]
4. Ocular hypotensive effects and safety over 3 months of switching from an unfixed combination to latanoprost 0.005%/timolol maleate 0.5% fixed combination.
Inoue K; Okayama R; Higa R; Sawada H; Wakakura M; Tomita G
J Ocul Pharmacol Ther; 2011 Dec; 27(6):581-7. PubMed ID: 22011049
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of the fixed combinations latanoprost/timolol versus dorzolamide/timolol in patients with elevated intraocular pressure.
Shin DH; Feldman RM; Sheu WP;
Ophthalmology; 2004 Feb; 111(2):276-82. PubMed ID: 15019375
[TBL] [Abstract][Full Text] [Related]
6. Fixed Combination of Travoprost and Timolol Maleate Reduces Intraocular Pressure in Japanese Patients with Primary Open-Angle Glaucoma or Ocular Hypertension: A Prospective Multicenter Open-Label Study.
Nakano T; Mizoue S; Fuse N; Iwase A; Matsumoto S; Yoshikawa K
Adv Ther; 2015 Sep; 32(9):823-37. PubMed ID: 26424331
[TBL] [Abstract][Full Text] [Related]
7. The efficacy and safety of bimatoprost/timolol maleate, latanoprost/timolol maleate, and travoprost/timolol maleate fixed combinations on 24-h IOP.
Guven Yilmaz S; Degirmenci C; Karakoyun YE; Yusifov E; Ates H
Int Ophthalmol; 2018 Aug; 38(4):1425-1431. PubMed ID: 28616797
[TBL] [Abstract][Full Text] [Related]
8. Additive intraocular pressure reduction effect of fixed combination of maleate timolol 0.5%/dorzolamide 2% (Cosopt) on monotherapy with latanoprost (Xalatan) in patients with elevated intraocular pressure: a prospective, 4-week, open-label, randomized, controlled clinical trial.
Hatanaka M; Reis A; Sano ME; Susanna R
J Glaucoma; 2010; 19(5):331-5. PubMed ID: 19730119
[TBL] [Abstract][Full Text] [Related]
9. Switching from latanoprost to fixed-combination latanoprost-timolol: a 21-day, randomized, double-masked, active-control study in patients with glaucoma and ocular hypertension.
Olander K; Zimmerman TJ; Downes N; Schoenfelder J;
Clin Ther; 2004 Oct; 26(10):1619-29. PubMed ID: 15598478
[TBL] [Abstract][Full Text] [Related]
10. Changes in intraocular pressure following a switch from latanoprost monotherapy to latanoprost/timolol fixed combination therapy in patients with primary open-angle glaucoma or ocular hypertension: results from a clinical practice database.
Lazaridou MN; Montgomery DM; Ho WO; Jaberoo D
Curr Med Res Opin; 2008 Oct; 24(10):2725-8. PubMed ID: 18713491
[TBL] [Abstract][Full Text] [Related]
11. Intraocular pressure-lowering effects of latanoprost monotherapy versus latanoprost or pilocarpine in combination with timolol: a randomized, observer-masked multicenter study in patients with open-angle glaucoma. Italian Latanoprost Study Group.
Bucci MG
J Glaucoma; 1999 Feb; 8(1):24-30. PubMed ID: 10084271
[TBL] [Abstract][Full Text] [Related]
12. Tolerability, quality of life, and persistency of use in patients with glaucoma who are switched to the fixed combination of latanoprost and timolol.
Dunker S; Schmucker A; Maier H;
Adv Ther; 2007; 24(2):376-86. PubMed ID: 17565929
[TBL] [Abstract][Full Text] [Related]
13. A study of the safety and efficacy of travoprost 0.004%/timolol 0.5% ophthalmic solution compared to latanoprost 0.005% and timolol 0.5% dosed concomitantly in patients with open-angle glaucoma or ocular hypertension.
Rhee DJ; Peace JH; Mallick S; Landry TA; Bergamini MV;
Clin Ophthalmol; 2008 Jun; 2(2):313-9. PubMed ID: 19668722
[TBL] [Abstract][Full Text] [Related]
14. Short-Term Efficacy and Safety of Switching from a Latanoprost/Timolol Fixed Combination to a Latanoprost/Carteolol Fixed Combination.
Inoue K; Piao H; Iwasa M; Ishida K; Tomita G
Clin Ophthalmol; 2020; 14():1207-1214. PubMed ID: 32440086
[TBL] [Abstract][Full Text] [Related]
15. A 12-week, randomized, double-masked study of fixed combination latanoprost/timolol versus latanoprost or timolol monotherapy.
Palmberg P; Kim EE; Kwok KK; Tressler CS;
Eur J Ophthalmol; 2010; 20(4):708-18. PubMed ID: 20099236
[TBL] [Abstract][Full Text] [Related]
16. A 12 week study comparing the fixed combination of latanoprost and timolol with the concomitant use of the individual components in patients with open angle glaucoma and ocular hypertension.
Diestelhorst M; Larsson LI;
Br J Ophthalmol; 2004 Feb; 88(2):199-203. PubMed ID: 14736774
[TBL] [Abstract][Full Text] [Related]
17. Fixed combination of travoprost and timolol maleate reduces intraocular pressure in Japanese patients with primary open-angle glaucoma or ocular hypertension: analysis by prostaglandin analogue.
Nakano T; Mizoue S; Fuse N; Iwase A; Matsumoto S; Yoshikawa K
Clin Ophthalmol; 2017; 11():55-61. PubMed ID: 28053501
[TBL] [Abstract][Full Text] [Related]
18. A 6-week, double-masked, parallel-group study of the efficacy and safety of travoprost 0.004% compared with latanoprost 0:005%/timolol 0.5% in patients with primary open-angle glaucoma or ocular hypertension.
Franks WA; Renard JP; Cunliffe IA; Rojanapongpun P
Clin Ther; 2006 Mar; 28(3):332-9. PubMed ID: 16750448
[TBL] [Abstract][Full Text] [Related]
19. Comparison of dorzolamide/timolol and latanoprost/timolol fixed combinations on diurnal intraocular pressure control in primary open-angle glaucoma.
Eren MH; Gungel H; Altan C; Pasaoglu IB; Sabanci S
J Ocul Pharmacol Ther; 2012 Aug; 28(4):381-6. PubMed ID: 22320418
[TBL] [Abstract][Full Text] [Related]
20. 24-hour efficacy of travoprost/timolol BAK-free versus latanoprost/timolol fixed combinations in patients insufficiently controlled with latanoprost.
Konstas AG; Voudouragkaki IC; Boboridis KG; Haidich AB; Paschalinou E; Giannopoulos T; Dragoumis ND; Makridis AK; Kahook MY
Adv Ther; 2014 Jun; 31(6):592-603. PubMed ID: 24919410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
